Objectives: Tropomyosins (TMs) are cytoskeletal microfilament proteins present in all eukaryotic cells. Human TM isoform 5 (hTM5) is the predominant isoform in colonic epithelial cells. Antibodies against hTM5 are found both in the sera and in the mucosa of patients with ulcerative colitis (UC) but not Crohn's disease (CD). We investigated whether anti-hTM5 autoantibodies are pathogenic.
Methods: Normal-appearing colonic mucosal biopsy specimens were incubated with autologous serum. After 45 min, deposition of the complement component C3b was identified by indirect immunofluorescence assay (IFA). Additional specimens were incubated with autologous serum fixed in formalin, and their architecture was examined by hematoxylin and eosin (H&E) staining.
Results: For 79% of UC patients, autologous serum caused C3b staining along the colonic epithelium. Recombinant hTM5 or anti-hTM5 monoclonal antibody blocked serum-induced C3b deposition. Immunoglobulin G (IgG) antibody and affinity-purified anti-hTM5 IgG antibody from UC sera with complement caused C3b deposition, indicating specificity of hTM5 as an autoantigen. When analyzed by H&E staining, sera obtained from 71% of UC patients caused a significant loss of epithelium. This process was inhibited by Fc fragments, indicating that it is complement mediated. With medium, normal, or CD serum, there was no C3b deposition or morphological changes of the colonic epithelium, indicating disease specificity. The ileal mucosa was not affected by UC sera, suggesting specificity for the colon. In UC mucosa, expression of hTM5 increased.
Conclusions: hTM5 acts as an autoantigen in UC. hTM5-specific IgG autoantibody in sera from UC patients induces C3b deposition and destruction of colonic epithelial cells, suggesting a direct pathogenic effect. If used as a diagnostic test to distinguish UC from CD, IFA would have 79% sensitivity and 100% specificity. Development of blocking antibodies may lead to novel therapies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/ajg.2009.455 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Proteolytic activity of secreted proteases from pathogenic leptospires and effects on phagocytosis by murine macrophages.
Microbes Infect
January 2025
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil. Electronic address:
Leptospirosis is a zoonosis caused by spirochete Leptospira. Pathogenic leptospires evade the Complement System, enabling their survival upon contact with normal human serum in vitro. In a previous study, we demonstrated that proteases secreted by pathogenic leptospires cleave several Complement proteins, including C3 and the opsonins C3b and iC3b.
View Article and Find Full Text PDFComplement activation drives the phagocytosis of necrotic cell debris and resolution of liver injury.
Front Immunol
January 2025
Laboratory of Molecular Immunology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Cells die by necrosis due to excessive chemical or thermal stress, leading to plasma membrane rupture, release of intracellular components and severe inflammation. The clearance of necrotic cell debris is crucial for tissue recovery and injury resolution, however, the underlying mechanisms are still poorly understood, especially . This study examined the role of complement proteins in promoting clearance of necrotic cell debris by leukocytes and their influence on liver regeneration.
View Article and Find Full Text PDFC3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation.
Front Nephrol
October 2024
Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.
C3 glomerulopathy (C3G) is an ultra-rare complement-mediated kidney disease caused by to the deregulation of the alternative pathway (AP) of proximal complement. Consequently, all effector loops of the complement are active and can lead to pathologies, such as C3a- and C5a-mediated inflammation, C3b opsonization, surface C3b-mediated AP C3 convertase assembly, C3 cleavage product deposition in the glomerulus, and lytic C5b-9/MAC cell damage. The most common pathologic mechanisms are defective chronic alternative pathway deregulation, mostly occurring in the plasma, often causing C3 consumption, and chronic complement-mediated glomerular damage.
View Article and Find Full Text PDFUnveiling the impact of TolC efflux protein on host tissue adherence, complement evasion, and diagnostic potential.
Infect Immun
November 2024
Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, India.
Article Synopsis
- The TolC protein is an outer membrane efflux protein with high sequence conservation among pathogenic species, suggesting its importance in virulence.
- * Structural modeling shows that it is composed of six β-strands and 10 α-helices, which supports its function similar to other bacterial efflux proteins.
- * Recombinant TolC has potential as a diagnostic marker due to its ability to interact with host tissues and proteins, enhancing pathogen adhesion and immune evasion.
Dog complement system is less effective against Leishmania infantum than human complement.
Vet Parasitol
December 2024
Laboratório de Fisiologia de Insetos Hematófagos, Departamento de Parasitologia, ICB, Universidade Federal de Minas Gerais, Caixa postal 486, Belo Horizonte, MG CEP: 31270-901, Brazil. Electronic address:
Article Synopsis
- * This study aimed to compare how well the complement systems in humans and dogs can kill L. infantum, showing that human serum was more effective than dog serum.
- * Although dog serum was generally less effective, infected dogs had a stronger immune response than non-infected ones, highlighting that dogs are more susceptible to visceral leishmaniasis than humans.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!